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Objectives. Todate, theefficacyof acceptance and commitment therapy (ACT) for stroke
survivors has not beenestablished.The aimof this studywas to evaluate the efficacyof group-
based ACT for stroke survivors in comparison with treatment as usual (TAU) controls.
Methods. Fifty-three participants were randomly assigned either to group-based ACT
(ACTivate Your Life after Stroke) or to a TAU control group (60% male; mean age:
63 years). The ACT intervention consisted of four weekly 2-hr didactic group sessions.
Therapeutic effects were measured by examining changes in depression (primary
outcome), anxiety, hope, health-related quality of life, self-rated health status, and mental
well-being. Measures were completed at pre-treatment, post-treatment, and 2-month
follow-up. A mixed-design repeated-measures multivariate ANOVA was conducted to
analyse the findings.
Results. Analysis based on intention to treat found that compared to participants in the
TAU control, group-based ACT significantly reduced depression and increased self-rated
health status and hopefulness in stroke survivors, with medium effect sizes. Significantly
more participants reached clinically significant change of depression in the ACT
intervention in comparison with the control group.
Conclusions. The results correspond with previous studies of group-based ACT with
other long-term conditions. The findings from this current study suggest group-based
ACT may have promising utility and could offer a suitable low-intensity psychological
intervention for stroke survivors. However, further large-scale research is required.
Practitioner points
 Acceptance and commitment therapy (ACT), delivered didactically to groups of stroke survivors,
proved feasible and acceptable.
 ACT had benefits, relative to treatment as usual, for depression, health status, and hope.
 Several secondary outcome variables did not show dependable benefit for ACT: anxiety; health-
related quality of life; and mental well-being.
 Results should be treated as preliminary as the sample size was small, blinding was not possible,
concomitant treatments were not monitored, and there was no attention control condition.
 Despite these limitations, group-basedACTmerits further study as a potentially effective intervention.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which
permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no
modifications or adaptations are made.
*Correspondence should be addressed to Reg Morris, Cardiff University, 70 Park Place, Tower building, 11th floor, Cardiff CF10
3AT, UK (email: Reg.Morris@wales.nhs.uk).
DOI:10.1111/bjc.12198
1
Stroke is defined as ‘rapidly developing clinical signs of focal (or global) disturbance of
cerebral function, with symptoms lasting 24 hrs or longer, or leading to death’ (WHO
Monica Project Principal Investigators, 1988). Approximately 17 million strokes occur
every year resulting in 5.9 million deaths and 33million stroke survivors living worldwide
(Feigin et al., 2014). Stroke affects many physical functions, and consequently, 40% of
stroke survivors are discharged from hospital requiring support with activities of daily
living (Royal College of Physicians, 2015). Stroke is considered to be one of the most
common causes of complex disability, affecting over half of all stroke survivors (Adamson,
Beswick,&Ebrahim, 2004). Theworldwideburden of stroke-related disability, illness, and
premature death is set to double by 2030 (Feigin et al., 2014).
Psychological disabilities are common (Stroke Association, 2013). The prevalence of
post-stroke depression is 31–33% (Hackett & Pickles, 2014) with 55% of stroke survivors
experiencing depression in the 15 years after stroke (Ayerbe, Ayis, Wolfe, & Rudd, 2013;
Hackett, Yapa, Parag, & Anderson, 2005). The incidence of anxiety up to 10 years post-
stroke ranges from17% to24%,with 57%experiencing anxiety during this period (Ayerbe,
Ayis, Crichton, Wolfe, & Rudd, 2014). Moderate and severe fatigue affects 57% of stroke
survivors (Lerdal et al., 2011). The Stroke Association (2016) found that 73% of stroke
survivors lacked confidence, 56% felt people treated them differently, and 55% felt unable
to care for their families as before. Stroke-related comorbidities are associated with
reduced quality of life (Bays, 2001; Godwin, Ostwald, Cron, & Wasserman, 2013; Sturm
et al., 2004), increased mortality (Ayerbe et al., 2013), increased health care utilization
(Appleby, Thompson, &Galea, 2012; Ghose,Williams, & Swindle, 2005; van Eeden et al.,
2016), and reduced functional recovery (Gillen, Tennen, McKee, & Gernert-Dott, 2001).
Psychological interventions for stroke survivors
There is a lack of clarity regarding effective psychological interventions for stroke
survivors (Royal College of Physicians, 2016). A randomized controlled trial (RCT) found
cognitive behavioural therapy (CBT) to be ineffective with stroke survivors and reported
that cognitive strategies were challenging for participants to implement (Lincoln &
Flannaghan, 2003). Several systematic reviews have concluded that there is limited
evidence for the efficacy of psychosocial therapies including problem-solving, goal
setting, psychoeducation, and social support (Hackett, Anderson, House, &Halteh, 2008;
Hackett, Anderson, House, &Xia, 2008; Sugavanam,Mead, Bulley, Donaghy, & vanWijck,
2013). Moreover, condition-specific reviews have concluded that there is only weak
evidence for efficacy of treatments for several common post-stroke conditions: depres-
sion (Hackett, Anderson, House, & Xia, 2008); anxiety (Knapp et al., 2017); fatigue (Wu
et al., 2015); executive functioning (Chung, Pollock, Campbell, Durward, & Hagen,
2013); and cognitive function (Gillespie et al., 2015; Loetscher & Lincoln, 2013).
The UK National Clinical Guidelines for Stroke (Royal College of Physicians, 2016)
propose brief psychological interventions for all stroke survivors with, or at risk of,
depression or anxiety. Recommended interventions include motivational interviewing
(MI), problem-solving therapy, or behavioural therapy (adapted cognitive behaviour
therapy) (Royal College of Physicians, 2016). An RCT reported that MI, delivered 1:1 over
four sessions, showed significant effects on mood at 3 months after stroke in comparison
with a TAU group (Watkins et al., 2007) and improved mood and reduced mortality at
12 months (Watkins et al., 2011). Behavioural therapy, compared with TAU in an RCT,
produced significant improvements in self-reported and observer-rated mood and self-
esteem at 3 months in stroke survivors with aphasia and low mood (Thomas, Walker,
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Macniven, Haworth, & Lincoln, 2013). Cost analysis showed some savings in resource
utilization at 6-month follow-up in comparison with a TAU group (Humphreys, Thomas,
Phillips, & Lincoln, 2014). Group-based problem-solving therapy significantly improved
task-oriented coping but not disease-specific quality of life in stroke survivors at 6 months
in comparison with a TAU control (Visser et al., 2015). Despite these few encouraging
findings, the psychological interventions required resource-intensive delivery formats
utilizing 1:1 therapy or numerous group session. Therefore, there are limited intervention
options for stroke survivors; yet almost three-quarters of stroke survivors experiencing
emotional distress felt their psychological needs were not being met (McKevitt et al.,
2011). This potentially hampers recovery (Gillen et al., 2001) and adds to the health
service resource burden produced by long-termconditions (Department ofHealth, 2012),
thus highlighting the pressing need to evaluate a greater range of therapeutic approaches
for stroke (Kangas & McDonald, 2011; Soo, Tate, & Lane-Brown, 2011) with a focus on
cost-effective delivery formats, such as group-based interventions (Hunsley, 2002).
Acceptance and commitment therapy
Acceptance and commitment therapy (ACT) proposes that psychological distress is a
natural aspect of human experience. Its primary aim is to promote acceptance and not to
rid a person of their distress. ACT aims to increase ‘psychological flexibility’ which allows
pursuit of a valued life despite physical limitations, painful thoughts, feelings, or
sensations (Harris, 2013). There is a growing body of research in support of ACT across a
wide range of clinical populations (Graham, Gouick, Krahe, & Gillanders, 2016; Ost.,
2014; Ruiz, 2012; Swain, Hancock, Dixon, Koo, & Bowman, 2013; Veehof, Trompetter,
Bohlmeijer, & Schreurs, 2016). Group-based ACT has been applied to several health
conditions including cancer, multiple sclerosis, epilepsy, diabetes, and chronic pain with
promising findings in reducing depression, anxiety, and disability and increasing
acceptance and other condition-specific outcomes (Gregg, Callaghan, Hayes, & Glenn-
Lawson, 2007; Kemani et al., 2015; Lundgren, Dahl, Melin, &Kies, 2006; Lundgren, Dahl,
Yardi, & Melin, 2008; McCracken, Sato, & Taylor, 2013; Mohabbat-Bahar, Maleki-Rizi,
Akbari, &Moradi-Joo, 2015;Nordin&Rorsman, 2012;Wetherell et al., 2011).Moreover, a
single case report found benefits for ACT with an adult experiencing post-stroke anxiety
(Graham, Gillanders, Stuart, & Gouick, 2014). ACT has a number of characteristics that
suggest its suitability for stroke:
 It adopts a health model rather than an illness model (Hayes, Strosahl, &Wilson, 1999)
and is conducive to the promotion of well-being rather than simply the removal of
symptoms.
 Its emphasis on acceptance of distress and ‘getting on with life’ is suited to stroke
because, in many people, physical effects such as hemiplegia are enduring and even
psychological effects such as anxiety may persist for many years (Astrom, 1996).
 ACT seeks to change the functions of cognitions about a person’s condition by teaching
them to distinguish between a thought and the event itself. It does not expect thoughts
to be altered or reduced in frequency (like traditional CBT)—something that may be
difficult for a person with a major, persistent condition such as aphasia or hemiplegia.
 The inclusion of mindfulness and ‘being in the present’ encourages a person to make
contact with their surroundings and to be open to experiences beyond their disability
and distress.
 ACT promotes the sense of self (‘self-as-context’) which helps build a sense of an
enduring and observing self that is separate from the experience of distress and life’s
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tribulations. This emphasis on self-as-context is potentially helpful with detrimental
change in self-identity after stroke (Lapadatu & Morris, 2017).
 The discovery of a person’s core values and the facilitation of their use in value-based
goal setting and ‘committed action’ are key features of ACT that may represent an
improvement on the traditional goal setting practice in strokewhich has been criticized
(Sugavanam et al., 2013; Plant, Tyson, Kirk, & Parsons, 2016).
Objectives of current study
The aimwas to assess the efficacy of brief group-basedACT for stroke survivors (‘ACTivate
Your Life after Stroke’) in comparisonwith a treatment as usual (TAU) control group using
random allocation to conditions.
Non-acceptance of the psychological effects of stroke-related disability is associated
with depression after controlling for age, gender, original stroke severity, and current
disability at 1- and 9-month follow-ups (Townend, Tinson, Kwan, & Sharpe, 2010).
Therefore, it was hypothesized that stroke survivorswho attend the ACT interventionwill
exhibit a greater reduction in depression (primary outcome) across pre-treatment, post-
treatment, and follow-up time points, in comparison with the control group. It was also
hypothesized that similar benefits of ACT would be observed for anxiety, health-related
quality of life (HRQoL), self-reported health status, hopefulness,1 and mental well-being
(secondary outcomes).
Methods
Participants and procedure
This studywas advertised tomembers of the stroke clinical teams across threeNHS sites in
SouthWales and one in southwest England. Leaflets detailing the course content and aims
(‘a short course to help you get on with your life after stroke’) were distributed to the
clinicians topass on to their patientswhomet the inclusion criteria of at least one clinically
diagnosed stroke,were discharged fromhospital,were over 18 years old, anddid not have
severe communication difficulties (e.g., aphasia) or cognitive impairments. Stroke
survivors were not eligible if they had another acquired brain injury (e.g., traumatic brain
injury, encephalitis, tumours), a diagnosed degenerative condition (e.g., dementia), or a
severe mental illness (e.g., psychosis).
Internet software (www.randomizer.org) generates a random number sequence to
determine group allocation, and a parallel group study design was utilized. Participants
interested in this study were referred by members of the clinical team to a designated
person within each site (not the researcher), who was responsible for enrolling
participants and group allocation. Once participants consented (in ignorance of the
next assignment in the sequence), they were consecutively randomized to conditions.
No restrictions to randomization were used. Letters were then sent to participants
indicating which group they had been allocated to and their course dates. For obvious
reasons, this study could not be blinded. All outcome measures were collected by the
researcher at pre-intervention (immediately prior to the first session), post-intervention
(immediately following the final session), and at 2-month follow-up, which were
1Hopefulness was selected as a process measure in preference to the Acceptance and Action Questionnaire (AAQ; Bond et al.,
2004) as a non-randomized pilot study (Ivey-Williams, 2015) indicated that the AAQ may not be suitable for stroke patients.
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distributed by post. The control group responded at the same time points, returning
responses by post or over the telephone. Prepaid self-addressed envelopes were
provided for postal returns. No monetary incentives were used to recruit or retain
participants.
Study conditions
ACT intervention
The ACT intervention, ‘ACTivate Your Life after Stroke’, consisted of 2-hr weekly didactic
PowerPoint group sessions, for four consecutive weeks. The intervention is described in
more detail in Cartwright and Hooper (2017). In sessions one and four, an extra half an
hourwas allocated for study questionnaire completion. Due to the trans-diagnostic nature
of ACT (Lang et al., 2012), carerswere invited to the course butwere not part of the study
analysis. As the intervention was didactic and non-interactive, the presence of carers was
not expected to inhibit the survivors, but it may have enhanced confidence and sense of
support.
The intervention was developed from Professor Neil Frude’s ‘ACTivate your life’
course, which has been employed across NHS mental health services within South
Wales, UK (Cartwright & Hooper, 2017), and has received positive appraisal from
Steven Hayes, co-founder of ACT (S. C. Hayes, personal communication to Prof N.
Frude, 21/12/2014). The material was manualized and psychoeducational in nature,
delivered by Microsoft PowerPoint with several ACT-based individual activities
throughout, such as guided mindfulness practices. The mental health version of the
course was adapted for stroke in collaboration with stroke survivors and carers.
Changes included reducing contrasting colours, simplifying the language and number
of words on the slides, and inclusion of stroke specific examples. The modified
version was used across all four sites. The session-by-session outline is illustrated in
Table 1. A handout was provided for each session which included a session summary
and suggested home activities.
Courses were run in community venues, for example, libraries across four sites
(three NHS in south Wales and one-third sector organization in south west England).
Sessions had at least two facilitators consisting of clinical psychologists, assistant
psychologists, or stroke care co-ordinators. There was at least one clinical
psychologist within the presenting team at each site. To ensure fidelity, all of the
course facilitators received the same intensive 2 day training facilitated by Prof. Neil
Frude and received clinical supervision. The didactic nature of the intervention, in
which the material was presented on slides and read by the facilitators, further
ensured fidelity.
TAU control group
Participants in the control group followed their usual treatments. Thismeant that they had
access, should they choose, to community services that are available to all, for example,
GP, charity support, or online resources. At the time of this study, therewere nodedicated
local NHS community stroke services for stroke survivors with psychological difficulties
beyond 6 weeks after discharge. The control group were offered the ACT intervention,
after the 2-month follow-up, which consisted of the exact same material, course
facilitators, and time period as the first group.
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Measures
Socio-demographical information
Information was collected regarding: age, gender, date of first stroke and most recent
stroke (if applicable), type and location of stroke (if known), employment status, living
arrangements, and experience of mental health conditions since stroke and therapy
received, if applicable.
Primary measure
Depression
Depression was chosen as the primary outcome as it is widely used as such in stroke
research andhad a strong associationwith recovery (Ayerbe et al., 2013) aswell as a range
of other key outcomes such as quality of life, increased use of health services, and greater
risk of hospitalization and institutionalization (Lincoln, Kneebone, Macniven, & Morris,
2012). It has also been found to be associated with the important ACT process of
acceptance of disability after stroke (Townend et al., 2010). The Patient Health
Questionnaire-9 (PHQ-9) measure was used to screen for depression and includes items
about affect, behaviour, and somatic symptoms. It is widely used and had good validity
(sensitivity of 88% and specificity of 88%), internal reliability (Cronbach’s a of .89), and
test–retest reliability (correlation = .84) in a primary care sample (Kroenke, Spitzer, &
Williams, 2001) andperformswell as a screening tool for post-stroke depression (Williams
et al., 2005).
Secondary measures
Anxiety
The Generalized Anxiety Disorder-7 measure was used to screen for anxiety (Spitzer,
Kroenke, Williams, & Lowe, 2006). It had good validity (sensitivity of 89% and specificity
of 82%), internal reliability (Cronbach’s a of .92), and test–retest reliability (intraclass
Table 1. Session-by-session outline of ‘ACTivate Your Life after Stroke’ course
Session Content
Week one: You are not your mind Creating the distinction between actions that are under our own
(conscious, deliberate) control and actions that are controlled by
our mind (e.g., on ‘autopilot’) including experiences of self-
criticism and rumination. Introduced the idea of developing a
viewpoint fromwhich one can observe thoughts and feelings, non-
judgementally
Week two: Facing up to life Focus on acceptance (not resignation) andwillingness to experience
unpleasant feelings and sensations (e.g., pain or anxiety) without
attempts to fight, avoid or suppress them, which can causes long-
term suffering when this gets in the way of meaningful activity
Week three: Being mindful Thoughts are thoughts, not facts. Several examples of thought
defusion exercises presented. Explanation ofmindfulness and non-
interactive activities completed (e.g., body scan)
Week four: Living wisely, living well Identification of individual values, distinction between values and
goals and examples of committed action discussed
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correlation; ICC = .83) in a primary care sample. It is also moderately good at screening
for a variety of other anxiety disorders (Kroenke, Spitzer, Williams, Monahan, & Lowe,
2007).
Health-related quality of life
The EQ-5D-5L (Herdman et al., 2011) had good internal reliability (ICC = .57) and test–
retest reliability (ICC = .69) across health samples (Janssen, Birnie, Haagsma, & Bonsel,
2008) and has been validated in stroke samples (Dorman, Waddell, Slattery, Dennis, &
Sandercock, 1997; Golicki et al., 2015). Scores from this current study were converted to
index value sets as recommended by the EuroQol Group as these index value sets reflect
the health state of the general population in any given country (Devlin, Shah, Feng,
Mulhern, & van Hout, 2018).
Self-reported health status
Part two of the EQ-5D-5L (Herdman et al., 2011)was used tomeasure self-reported health
status. This consists of a 20 cmvisual analogue scalewhich asks users to indicate from0 to
100 ‘how good is your health today?’ Test–retest reliability was reported as ICC = .51
across health samples (Janssen et al., 2008) and has been validated in stroke samples
(Dorman et al., 1997; Golicki et al., 2015).
Hope
The Adult Hope Scale (Snyder et al., 1991) was used to assess hope. Total scores from
the eight active items range from 0 to 48, with higher scores indicating greater
hopefulness. The questionnaire was internally consistent (Cronbach’s a ranging from
.74 to .84); showed good test–retest reliability (Cronbach’s a ranging from .73 to .85)
and good validity across student and clinical populations (Snyder, 2002; Snyder et al.,
1991).
Mental well-being
Warwick and Edinburgh Mental Well-being Scale had good validity, internal consistency
(Cronbach’s a = .91), and test–retest reliability (ICC = .83) in general population and
student samples (Tennant et al., 2007). It comprises of 14 items, and a higher score
indicates greater mental well-being. Mental well-being describes positive states of being,
thinking, behaving, and feeling.
Sample size
A similar randomized study (McCracken et al., 2013) using the PHQ-9 to investigate the
impact of group-based ACT in a health setting found the ACT group, in comparisonwith a
TAU group, was significantly less depressed at post-treatment (d = 0.46) and at 3-month
follow-up (d = 0.58). Based on these effect sizes, a power analysis was conducted using
G* Power (Faul, Erdfelder, Lang, &Buchner, 2007). In order for sufficient power (.80) and
using standard parameters of alpha = .05, a total sample size of between 40 and 64
participants was required.
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Statistical methods
IBM SPSS Statistics 23 (IBM, Released 2014) statistical program was used to analyse the
data. An intention-to-treat approachwas usedwith imputation ofmissing data by last value
carried forward (Streiner & Geddes, 2001). Effect sizes are reported as partial eta-squared
(partialȠ2) and are categorized against the suggested values of .01, .06, and .14 to indicate
small, medium, or large effects (Richardson, 2011).
A mixed-design repeated-measure ANOVA was used to analyse the interaction
between the two groups and outcomemeasures across the three time points. Participants
from each of the intervention and TAU control groups were combined into a single
‘intervention’ and ‘TAU’ group for all statistical analysis. Ideally, a nested design would
have been employed. However, the same inclusion and exclusion criteria applied to all
groups and the didactic PowerPoint format engendered uniformity across the interven-
tion groups. Given this uniformity, and small number of groups involved, pooling was the
preferred strategy. Two mixed-design repeated-measures ANOVAs were conducted to
showwhether there were significant differences pre-intervention to post-intervention or
pre-intervention to 2-month follow-up. To assess group differences in clinically significant
change for the primary outcome of depression, a chi-square analysis was conducted.
Ethical approval
This study was approved by the London – City & East NHS Research Ethics Committee.
Results
Participant flow
Figure 1 illustrates the flow of participants through each arm of the study. Data on those
initially invited to the study by the clinical teams could not be recorded as ethical approval
allowed details to be collected only after consent. Fifty-three participants were recruited
in total, and analysis was completed on all recruited participants in their original assigned
groups, ACT N = 26, and control N = 27. All 26 participants in the group-based ACT
intervention attended at least three of the four sessions, of which 19 (73.1%) attended all
four sessions. The attrition rate was low: 25 (96.2%) and 22 (84.7%) participants
completed the post-treatment and the 2-month follow-up assessments in the intervention
arm and 23 (85.2%) and 25 (92.6%) in the control arm. As a result of the low rate of
dropouts, the predictors of dropout were not subjected to further analysis. Total group
sizes varied from 6 to 22 attendees across the four groups, of which approximately 40–
50% were carers who were not eligible to participate in the study. In addition, clinical
teams offered the ACT course to a small number of their patients a short time before the
groups commenced, which was after study participants had been randomized; thus,
recruitment to the study was closed as any further participants could not be randomized.
The number of stroke survivorswho consented to participant in the research studywithin
each group varied from three to nine (Table 2).
Sample characteristics
Themeans and standard deviations of participant demographics and outcomemeasures at
baseline are summarized in Table 3. Independent sample t-tests were conducted with
Bonferroni correction, to compare the groups at pre-intervention. Significant differences
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were found for gender whereby the ACT group had significantly more males. Although
qualitative data were collected regarding stroke details (e.g., location and type), the data
were too heterogeneous to analyse. There were no significant differences between the
groups on the outcome measures at baseline.
Figure 1. Flow chart of participants in randomized groups.
Table 2. Group numbers for the research study
Group 1 (n) Group 2 (n) Group 3 (n) Group 4 (n) Total
ACT 7 7 3 9 26
Control 4 6 7 10 27
Acceptance and commitment therapy after stroke 9
Primary outcome
A mixed-design repeated-measures ANOVA revealed a significant time 9 group
interaction for depression, in favour of ACT over TAU, F (2, 102) = 3.87, p = .024,
with a medium effect size (partial Ƞ2 = .07). This interaction is shown in Figure 2,
and means and standard deviations are illustrated in Table 4. This group interaction
remained significant at pre-treatment to post-treatment analyses F (1, 51) = 4.10,
p = .048, with a medium effect size (partial Ƞ2 = .07) and pre-treatment to 2-month
follow-up analyses F (1, 51) = 5.90, p = .019, with a medium effect size (partial
Ƞ2 = .10). A paired t-test comparing post-treatment and follow-up scores for the
PHQ-9 showed no significant difference which is commensurate with maintenance
of gains.
Table 3. Participant characteristics at baseline (Mean [SD] or n [%])
Characteristics ACT (n = 26)
Control
(n = 27)
Overall
(n = 53) p Value
Mean age (years) 65.3 (11.9) 60.0 (15.6) 62.7 (13.9) .184
Gender (% male) 21 (80.8) 11 (40.7) 32 (60.4) .002*
Has had more than one stroke 6 (23.1) 8 (29.6) 14 (26.4) .538
Months since most recent stroke 14.1 (14.5) 13.1 (13.3) 13.6 (13.7) .824
Months since first stroke (if had multiple) 62.5 (73.7) 40 (37.1) 50 (50.8) .380
Age left education 18.5 (3.6) 17.0 (2.1) 17.8 (3.0) .090
Currently employed 4 (15.4) 10 (37) 14 (26.4) .05
Currently retired 19 (73.1) 13 (48.1) 32 (60.4) .124
Living circumstance
Living with carer 19 (73.1) 5 (18.5) 24 (45.3) .003
Living with someone who is not carer 3 (11.5) 12 (44.4) 15 (28.3)
Living alone 4 (15.4) 7 (25.9) 11 (20.8)
Not stated 0 (0) 3 (11.2) 3 (5.6)
Has previously received treatment
for a mental health condition since stroke
11 (42.3) 9 (33.3) 20 (37.7) .653
Treatment received
Medication 1 (3.8) 2 (7.4) 3 (5.7) .923
Psychological therapies 4 (15.4) 2 (7.4) 6 (11.3)
Both the above 3 (11.5) 1 (3.7) 4 (7.5)
Not stated 3 (11.5) 4 (14.8) 7 (13.2)
Study outcome measures at baseline
PHQ-9 12.46 (6.3) 10.85 (7.5) 11.65 (6.9) .402
GAD-7 9.77 (6.2) 7.85 (6.6) 8.79 (6.4) .280
EQ-5D-5L 0.65 (0.26) 0.61 (0.28) 0.63 (0.27) .554
Health (EuroQoL visual analogue) 59.62 (20.5) 55.67 (23.8) 57.6 (22.1) .521
AHS 40.77 (14.3) 43.37 (13.3) 42.09 (13.7) .496
WEMWBS 40.31 (10.5) 42.37 (12.7) 41.36 (11.6) .522
Notes. ACT = acceptance and commitment therapy; AHS = Adult Hope Scale; EQ-5D-5L = Euro-
quality of life; GAD-7 = Generalized Anxiety Disorder-7; PHQ-9 = Patient Health Questionnaire-9;
SD = standard deviation; TAU = treatment as usual; WEMWBS = Warwick and Edinburgh Mental
Well-being Scale.
*Significant value after Bonferroni correction (.05/17 = .0029).
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Caseness and clinically significant change
The numbers of cases of depression using the cut-off of 10 or above (Kroenke et al.,
2001) were 17 in the intervention group and 15 in the control group at pre-
intervention, 11 and 14 at post-intervention, and 8 and 12 at follow-up. PHQ-9 defines
clinically significant change as a score of ≤9 combined with improvement of 50% from
the pre-treatment scores (Kroenke et al., 2001; McMillan, Gilbody, & Richards, 2010).
At post-treatment, a significant group difference occurred, v(1) = 5.35, p = .021,
whereby 38.5% (N = 10) of the ACT group had reached a clinically significant change,
in comparison with 11.1% (N = 3) in the control group. This significant group
difference continued at 2-month follow-up in favour of ACT, v(1) = 13.55, p = .001:
The total number of participants in the ACT group exhibiting clinically significant
change from pre-treatment was 53.8% (N = 14), whereas in the control group, it was
7.4% (N = 2).
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Figure 2. Line graphs for each outcome measure across groups for the three time points.
FU = 2-month follow-up; Pre = pre-treatment baseline; Post = post-treatment.
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Secondary outcomes
A mixed-design repeated-measures MANOVA, with the secondary outcome measures
across the three phases, revealed a significant overall multivariate main effect for
time 9 group interaction, Wilks’ k = .56, F (10, 42) = 3.26, p = .003, partial Ƞ2 = .44.
Power to detect the effectwas .97. Given the significance of the overall test, the univariate
time 9 group interactions were examined and significant findings were obtained in
favour of ACT over TAU for self-reported health status F (1.75, 102) = 4.22, p = .022, and
hopefulness F (1.65, 102) = 4.22, p = .017, all with medium effect sizes (partial Ƞ2 = .08
for both variables). No significant effects were found for HRQoL, anxiety, or mental well-
being. These overall trends can be seen in Figure 2, and overall means and standard
deviations, together with Cronbach’s alpha for each measure at pre-test, are illustrated in
Table 4.
To assess the outcome measures between the groups and across time points, two
mixed-design repeated-measures MANOVAs were conducted to evaluate the interaction
from pre-treatment to post-treatment and then from pre-treatment to follow-up. Pre-
treatment to post-treatment analyses found a significant multivariate effect for the
time 9 group interaction, Wilks’ k = .70, F (5, 47) = 4.05, p = .004, partial Ƞ2 = .30.
Power to detect the effect was .93. Univariate main effects revealed significant findings in
favour of ACT in comparisonwith TAU for hopefulness F (1, 51) = 10.49, p = .002,with a
large effect size (partial Ƞ2 = .17). Although mental well-being did not reveal an overall
effect across the three time points in the initial repeated MANOVA, pre- to post-
intervention significance was reached in favour of ACT in comparison with TAU, F (1,
51) = 4.16, p = .047, with a medium effect size (partial Ƞ2 = .07). Self-reported health
status showed a strong trend in favour of ACT, but did not reach significance (p = .057).
Significant effects were not found for anxiety or HRQoL in this pre-/post-intervention
analysis.
Pre-treatment to follow-up analyses found a significant multivariate effect for
time 9 group interaction, Wilks’ k = .779, F (5, 47) = 2.67, p = .033, partial Ƞ2 = .22.
Power to detect the effect was .76. There were no significant univariate effects. Paired-
sample t-test comparing post-intervention with follow-up scores for all secondary
outcome variables showed no significant differences which is consistent with mainte-
nance of gains.
Discussion
This study found that the ACT intervention significantly reduced depression and
increased hopefulness and self-reported health status in stroke survivors in comparison
with the TAU control group, with medium effect sizes. However, there were several
factors that differed between the ACT and the TAU groups such as being offered a novel
treatment, joining a group class, attention, etc. Therefore, it is not possible to attribute the
effects to the ACT intervention itself in the absence of additional control measures or the
measurement of specific ACT-related processes, such as acceptance. The use of the AAQ
(Bond et al., 2011) was considered as a measure acceptance, but a pilot studywith stroke
survivors suggested that it may be necessary to adapt and revalidate such process
measures for the stroke population (Ivey-Williams, 2015).
The participants in the ACT group showed reduction in depression compared with
controls from pre-treatment to post-treatment which was maintained during the 2-month
follow-up period, with medium effect size. Nearly 54% of participants in the ACT group
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had had a clinically significant change in depression scores at the 2-month follow-up in
comparison with only 7% of the controls. In addition to the overall interaction, there was
an increase in hope scores in favour of ACT from pre-treatment to post-treatment. But this
was not maintained at follow-up due to an elevation of the control group’s scores. Self-
reported health status followed a similar pattern to that of hope. Finally, the outcome
variable for mental well-being did not produce overall significant differences across the
three time points, but pre-intervention to post-intervention analysis found significant
group differences in favour of ACT. Again, the effect was not maintained to follow-up.
There were no significant group differences on measures of HRQoL or anxiety. Possibly
physical abilities in everyday tasks, such as mobility, self-care, and pain/discomfort,
limited scope for increased participation in activities related to quality of life.
Alternatively, the 2-month follow-up may not have been sufficient for such life changes
to occur in response to the intervention. However, the ACT group did perceived their
ownhealth status as significantly better than the control group following the intervention.
It is unclear why anxiety showed no significant difference between groups. A systematic
review (Swain, Hancock, Hainsworth, & Bowman, 2013) concluded that there is support
for the efficacy of ACT in treating anxiety across a range of populations. Further studies are
required to clarify whether post-stroke anxiety can be ameliorated by ACT.
The reduction in depressive symptoms and the increase in self-reported health status
and hopefulness in the ACT group are particularly interesting in the context of the aims of
ACT,which does not primarily aim to reduce distress or improvehealth. Instead, ACT aims
to help people to live a valued life despite these unpleasant experiences (Harris, 2013).
However, the improved hopefulness in the ACT group makes theoretical sense as
participants were taught skills to take committed action to move towards a more
meaningful life. A conservative interpretation of this result, in line with the ACT
philosophy, is that the ACT intervention stimulated participants to experience a change of
relationship with their health difficulties as they learn to accept what they cannot change
and focus on achievable and meaningful goals. This could also explain the improvements
in reports of depressive symptoms which encompass physical and behavioural aspects of
function, as well as affect. An alternative explanation is that participants in the control
group had a negative reaction to the TAU allocation, and their hopefulness levels
decreased at post-intervention, but rose again at the 2-month follow-up, perhaps as a result
of being offered the ACT intervention after the study finished.
The significant reduction in depressive symptoms in the ACT group in comparison
with the controls mirrors findings of RCTs using group-based ACT with other physical
health conditions, such as chronic pain, fibromyalgia, and breast cancer patients (Luciano
et al., 2014; McCracken et al., 2013; Mohabbat-Bahar et al., 2015; Wicksell et al., 2013).
Compared to TAU or waiting list controls, group-based ACT demonstrated significant
improvements on depressive symptoms post-intervention (McCracken et al., 2013;
Wicksell et al., 2013; Luciano et al., 2014). These improvements weremaintained at 3- or
6-month follow-ups (Luciano et al., 2014; McCracken et al., 2013; Wicksell et al., 2013).
However, when group-based ACT was compared to active treatments such as CBT and
applied relaxation in chronic pain samples, therewere no significant differences between
the interventions; all groups reported a reduction in depressive symptoms (Kemani et al.,
2015;Wetherell et al., 2011). So the efficacy of ACT in comparisonwith other treatments
in stroke is an area requiring further research.
The increase in hopefulness is consistent with research that found benefits of an ACT
interventionwith cancer patients (Ghasemi, Dehghan, Farnia, Tatari, & Alikhani, 2016). It
is clinically important as higher levels of hope are associated with improved treatment
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adherence, ability to cope with illness and loss and also enhanced psychological
adjustment (Snyder, 2002; Van Servellen, Chang, Garcia, & Lombardi, 2002; Weis &
Speridakos, 2011).
Implications for service delivery
In the United Kingdom, many stroke units report no access to psychology services (Royal
College of Physicians, 2014); 40%of stroke survivors felt abandoned after leaving hospital;
50% did not receive any information or support for anxiety or depression; and two thirds
said their emotional needs were not met as well as their physical needs (Stroke
Association, 2013). Health care cost for patients with long-term conditions and comorbid
depression will typically be 45% greater than patients without comorbid depression
(Naylor et al., 2012). Due to the didactic nature of group-based ACT, it has potential to be
a cost-effective low-intensity psychological intervention as, in principle, large numbers of
people can attend a course. However, a group setting may be unacceptable for some
patients, and therefore, services should offer a range of interventions, tailored to patient
need (Royal College of Physicians, 2016).
Strengths and limitations
The group-based psychoeducational ‘ACTivate Your Life after Stoke’ intervention is
capable of being delivered by non-specialists following suitable training andwith support.
This ACT intervention was specifically adapted by a team of service users, carers, and
professionals from stroke services to ensure the presentation was suitable for the stroke
population. The intervention offered stroke survivors access to a community-based
psychological intervention, regardless of when their stroke occurredwhich is in linewith
guidance (Royal College of Physicians, 2016). This was the first study to explore the
outcome of tailored group-based ACT for stroke survivors.
Limitations of this study were its relatively small sample which would not permit
more sophisticated statistical analyses without compromising statistical power (e.g., a
nested design or analysis of covariance). Despite randomization, the control and
intervention samples differed significantly in gender composition and showed a near
significant difference for living arrangements. Neither factor is known to reliably
influence response to psychological intervention but replication with new, better-
matched samples are indicated. There was no control for use of concomitant
treatments and no data for those who declined to participate. The type of participants
that are willing to engage in group format psychological interventions, as opposed to
individual therapy or medication, may have produced a self-selected sample that biased
outcomes (Wylde, Marques, Artz, Blom, & Gooberman-Hill, 2014). This study was
unable to provide equality of therapy hours to compare against an active treatment or
undertake independent checks for treatment adherence. However, the intervention
was delivered by PowerPoint which facilitated adherence and facilitators received
supervision throughout the study.
Conclusions
This studywas designed to evaluate a group-basedACT intervention for stroke survivors, a
population for whom few psychological interventions are available. The encouraging
results of this current study should be seen as preliminary as the sample size was small in
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comparison with trials intended to produce conclusive results. However, we can
conclude that ACT is an acceptable and promising intervention following stroke.
Recommendations for further research include a larger sample, with active comparison
groups and to assess the cost-effectiveness of this intervention.
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